UK Markets close in 6 hrs 38 mins

Omeros Corporation (OMER)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
15.84+0.02 (+0.13%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close15.82
Bid15.82 x 800
Ask15.84 x 900
Day's range15.74 - 16.06
52-week range9.25 - 23.85
Avg. volume397,728
Market cap987.282M
Beta (5Y monthly)1.10
PE ratio (TTM)N/A
EPS (TTM)-2.44
Earnings date09 Aug 2021 - 13 Aug 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est37.43
  • Zacks

    Omeros (OMER) Reports Q2 Loss, Tops Revenue Estimates

    Omeros (OMER) delivered earnings and revenue surprises of 20.00% and 11.09%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

  • Business Wire

    Omeros Corporation Reports Second Quarter 2021 Financial Results

    SEATTLE, August 09, 2021--Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, immunologic diseases (e.g., complement-mediated diseases and cancers) and central nervous system disorders, today announced recent highlights and developments as well as financial results for the second quarter ended June 30,

  • Business Wire

    Omeros Corporation to Announce Second Quarter Financial Results on August 9, 2021

    SEATTLE, August 03, 2021--Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its second quarter financial results for the period ended June 30, 2021, on Monday, August 9, 2021, after the market closes. Omeros management will host a conference call and webcast that day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results as well as recent developments and highlights.